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Diosgenin, a naturally occurring steroid saponin found abundantly in legumes and yams, is a precursor of various synthetic
steroidal drugs. Diosgenin is studied for the mechanism of its action in apoptotic pathway in human hepatocellular carcinoma
cells. Based on DAPI staining, diosgenin-treated cells manifested nuclear shrinkage, condensation, and fragmentation. Treatment
of HepG2 cells with 40μM diosgenin resulted in activation of the caspase-3, -8, -9 and cleavage of poly-ADP-ribose polymerase
(PARP) and the release of cytochrome c. In the upstream, diosgenin increased the expression of Bax, decreased the expression of
Bid and Bcl-2, and augmented the Bax/Bcl-2 ratio. Diosgenin-induced, dose-dependent induction of apoptosis was accompanied
by sustained phosphorylation of JNK, p38 MAPK and apoptosis signal-regulating kinase (ASK)-1, as well as generation of the
ROS. NAC administration, a scavenger of ROS, reversed diosgene-induced cell death. These results suggest that diosgenin-induced
apoptosis in HepG2 cells through Bcl-2 protein family-mediated mitochndria/caspase-3-dependent pathway. Also, diosgenin
strongly generated ROS and this oxidative stress might induce apoptosis through activation of ASK1, which are critical upstream
signals for JNK/p38 MAPK activation in HepG2 cancer cells.
1.Introduction
Diosgenin is a steroidal saponin, which is found in a variety
of plants including fenugreek (Trigonella foenum graecum),
roots of wild yam (Dioscorea villosa), Solanum incaunm, and
Solanum xanthocarpum [1]. It has been reported to have
various eﬀects, such as a hypocholesterolemic action in rat,
or an antioxidant activity in HIV patients with dementia
[2, 3]. Diosgenin has been shown to exert anticancer eﬀects
against a wide variety of tumor cells, including breast cancer,
colorectal cancer, osteosarcoma, and leukemia [4–7]. The
antitumor eﬀects of diosgenin have been demonstrated to be
mediated through activation of p53, immune-modulation,
cell cycle arrest, modulation of caspase-3 activity, and induc-
tion of TRAIL death receptor DR5 [8–10]. A recent study has
shown that diosgenin inhibited proliferation and induced
apoptosis in HepG2 cells by inhibiting signal transducer and
activator of transcription (STAT3) signaling pathway [11].
Apoptosis is a programmed cell death process that
controlsnormaldevelopmentandhomeostasisinorganisms.
T h el o s so fa p o p t o t i cc o n t r o lc o n t r i b u t e st ot h es u r v i v a lo f
tumor cells, and the enhancement of cancer cell apoptosis
is one approach of controlling cancer by anticancer agents
[12]. At the biochemical level, apoptosis is mediated by the
activation of a class of cysteine proteases called caspases.
In mammalian cells, caspase activation mainly occurs either
through death receptor activation or mitochondrial mem-
brane permeabilization [13]. The mitochondrial pathway
of apoptosis is regulated principally by the Bcl-2 protein
family. In response to apoptotic signals, Bax, a proapoptotic
member of the Bcl-2 family, is redistributed from the cytosol
to the mitochondria. Conversely, overexpression of Bcl-2
protects apoptosis. Therefore, the ratio of expression of
the proapoptotic Bax protein and the antiapoptotic Bcl-2
protein ultimately determines cell death or survival in this
mitochondrial death pathway [14, 15].2 Evidence-Based Complementary and Alternative Medicine
One of the well-known intracellular signaling pathways
for apoptosis is the kinase cascade, which has been identiﬁed
as a transducing pathway of apoptotic signals initiated by
outside stimuli, mitogen-activated protein (MAP) kinases,
and their upstream kinases such as MAP kinase kinases [16].
Many stimuli such as anticancer drugs, irradiation, TNF-α,
and chemopreventive agents prompt cells to produce ROS
[17, 18]. It has been shown that ROS induces a number of
eventsincludingmitogen-activatedproteinkinases(MAPKs)
signal transduction pathways in mediating apoptosis [19,
20].
Apoptosis signal-regulating kinase (ASK)-1 is a member
of the ROS-sensitive MAP kinase kinases and it acts as a
redox sensor of cells [21]. ASK 1 is activated in response
to TNF-α, Fas, and oxidative stress. Overexpression of
inactive ASK1 can inhibit TNF-α or Fas-ligand-induced
cell death [22]. On the other hand, constitutively active
ASK1 overexpression has been shown to cause apoptosis
through mitochondrial-dependent caspase activation [23].
Thus, ASK1 appears to be a key player in the MAPK (p38
MAPK/JNK) control of cell death and cell survival.
Diosgenin has been shown to target multiple pathways of
tumorigenesis, including proliferation, apoptosis, angiogen-
esis, invasion, and tumor-induced immunosuppression in
various tumor cells and in vivo cancer models [1]. However,
no reports exist in the literature elaborating the eﬀect of
diosgenin on ROS-ASK1-MAPK signaling cascade in HepG2
cells. In this study, we investigated the involvement of ASK1
in the apoptotic process of HepG2 cells treated with a
chemopreventive agent, diosgenin. Here, we demonstrated
that diosgenin strongly generated ROS and this oxidative
stress induced apoptosis through activation of ASK1, which
are critical upstream signals for p38 MAPK/JNK activation
in HepG2 cancer cells.
2.MaterialandMethods
2.1. Cell Culture and Drug Treatment. Human hepatoma cell
line (HepG2) was cultured in RPMI (Gibco) supplemented
with10%fetalbovineserum(Gibco).Thecellswerecultured
at 37◦C in a humidiﬁed chamber with 95% air and 5%
CO2.Allexperimentswereperformedinplastictissueculture
ﬂasks (Falcon). HepG2 cells were seeded on 24 well plates
or 100mm culture dishes. After plating, cells were allowed
to adhere overnight and were then treated with chemical.
Diosgenin was purchased from Sigma and stored at −20◦C.
Diosgenin stock solutions were made in ethanol (100%) and
diluted in medium prior to use.
2.2. Determination of Cell Viability (MTT Assay). Cell via-
bility was determined by the MTT [3-(4,5-dimethylthiazol-
2yl)-2,5-diphenyltetrazolium bromide] assay. The cells were
seeded in 24-well plates at a density of 4 × 104 cells/well
and treated with Diosgenin at various concentration (0–
40μM)for24hand48h.Aftertheexposureperiod,media
were removed. Thereafter, the medium was changed and
incubated with MTT (0.1mg/mL) for 3h. The viable cell
number per dish is directly proportional to the production
of formazan, which was solubilized in isopropanol, and
measured spectrophotometrically at 570nm.
2.3. Apoptosis Assays. Fluorescence-associated cell sorting
(FACS) analysis was performed to discriminate between
intact and apoptotic cells. Staining for FITC-labeled annexin
V binding to membrane phosphatidylserine and propid-
ium iodide (PI) binding for cellular DNA was performed
according to the protocol provided by the manufacturer
(Boehringer Mannheim). Brieﬂy, cells (1 × 106 cells) were
suspended in buﬀer containing FITC-conjugated annexin
V and PI at appropriate concentrations. The samples were
analyzed by FACS Vantage using Cell Quest Software (Beck-
ton Dickinson) and 20,000 events from each sample were
acquired to ensure adequate data.
2.4. DAPI Staining. Cells (1 × 105) were plated onto 18mm2
coverslips in ﬂasks and cultured with complete medium.
After they were treated with diosgenin, the cells were ﬁxed
with 4% formaldehyde for 20min at room temperature and
were then washed with PBS. Cold methanol was added for
another 20min at room temperature followed by washes
with PBS by three times. The membrane permeable ﬂuores-
c e n td y eD A P I( 2μg/mL), which binds to chromatin of cells,
was added to the ﬁxed cells, and the cells were examined by
an inverted Olympus IX70 microscope (Japan). Apoptotic
cells were identiﬁed by condensation and fragmentation of
n u c l e i .F o re a c he x p e r i m e n t ,n u c l e if r o m1 0r a n d o mﬁ e l d so f
each coverslip were examined at ×200 magniﬁcation.
2.5. Western Blot Analysis. After the indicated diosgenin
treatment, the medium was removed, and the cells were
rinsed with PBS twice. After the addition of 0.6mL of cold
RIPA buﬀer (10mM Tris pH 7.5, 100mM NaCl, 1mM
EDTA, 0.5% Na-deoxycholate, 0.1% SDS, 1% Triton X 100)
and protease inhibitors, cells were scraped followed at 4◦C.
Cell lysate was then subjected to a centrifugation of 14,000 ×
gfor15minat4 ◦C.Resultantproteinsampleswereseparated
by an SDS-PAGE gel and transferred onto a polyvinylidine
diﬂoride membrane (PVDF, Millipore) membrane. Mem-
brane was stained by ponceu to conﬁrm uniform transfer
of all samples and then incubated in blocking solution
(PBS with 0.05% tween 20 and 5% non fat dry-milk)
for 1h at room temperature. The antibodies used in this
study, caspase-3, caspase-8, caspase-9, Bcl-2, Bax, Bid and
cytochrome c were obtained from Santa Cruz Biotechnology
Inc (Santa Cruz, CA), and p38, JNK, phospho-p38, and
phosphor-JNK were purchased from Upstate Cell Signaling.
The membrane was reacted ﬁrstly with desired primary
antibodies for 1h at room temperature. Membrane was
then incubated with appropriate horseradish peroxidase-
conjugated secondary antibody (Zymed) for 1h, washed
with PBST, and developed using the ECL kit.
2.6. ROS Assay. Intracellular generation of ROS was mea-
sured with carboxy-H2D C F D A( I n v i t r o g e n ) ,w h i c hi sac e l l -
permeable and nonﬂuorescent dye when loaded onto the
cells. This compound is oxidized by ROS to ﬂuorescent
carboxydichloroﬂuorescein (DCF) inside the cells. Brieﬂy,Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Cytotoxic EﬀectofdiosgenininHepG2 cells. (a)Cellswere treatedwith diosgenin by dose-dependent manner for24 and 48h.The
ratios of cell viability were measured by MTT assay. Data are presented as mean ± SD of six replicates from three independent experiments.
∗∗P<0.01 compared to control. (b) Nuclear alterations were observed by DAPI staining and ﬂuorescence microscopy (×100). After cells
were treated with diosgenin (0–40μM) for 48h, marked morphological changes of cell apoptosis such as condensation of chromatin and
nuclear fragmentations were found clearly using DAPI staining.
the cells seeded in 6-well plates (2 × 105 cells/well) and
treated with or without diosgenin were incubated with
5μMc a r b o x y - H 2DCFDA for 15min at 37◦C. Then the
cells were washed with phosphate buﬀered saline (PBS)
twice, trypsinized, and resuspended in OptiMem I medium.
The ﬂuorescence resulting from the rate of oxidation of
the dye in the cells was measured using a FACS with an
excitation wavelength of 480nm and an emission wavelength
of 530nm. The generation of ROS in HepG2 cells was also
veriﬁed by ﬂuorescence microscopy (Nicon, Japen). Cells
grown to conﬂuence were treated with or without diosgenin
in the presence of 5μMc a rb o x y - H 2DCFDA for the indicated
time and resuspended in fresh OptiMem I medium after
washing.Duringﬂuorescenceimaging,theilluminationlevel
was reduced to minimal level to prevent photosensitization
of the ﬂuorescent probe.
2.7. Statistical Analysis. All experiments were performed in
triplicates and the results were expressed as mean ± S.D.
Statistical signiﬁcances were analyzed by one-way analysis of
variance (ANOVA) with Duncan test. P value ≤ 0.05 was
considered statistically signiﬁcant (STATSTICA 2.0, USA).
3. Results andDiscussion
3.1. Cytotoxic Eﬀect of Diosgenin on HepG2 Cells. Ap r e v i o u s
study has shown that diosgenin inhibited proliferation and
induced apoptosis in HepG2 cells [11]. To conﬁrm whether
diosgenin inﬂuences the viability of hepatoma cells, HepG2
cells were challenged with diosgenin (0–40μM). Cytotoxicity
is measured by MTT assay following a brief during exposure.
Diosgenin markedly induced cell death in HepG2 cells in a
dose- and time-dependent manner as compared with vehicle
controls (Figure 1). Apoptosis is initially characterized by
morphological features, such as chromatin condensation,
nuclear fragmentation, and membrane blebbing [24]. In
the current study, morphological changes of cell apoptosis
such as condensation of chromatin and nuclear fragmen-
tation were clearly observed by DAPI staining after 24h of
diosgenin (Figure 1). Cell death was also assessed with ﬂow
cytometry after double staining with annexin V and PI. We
challengedthecellswithincreasingdosesofdiosgeninat24h
of treatment. According to Figure 2(a), the combined early
and late apoptotic cells (Annexin V positive) were elevated in
adose-dependentfashion.Consistentwiththeprogressionof
apoptosis,lateapoptoticcellsbecomedominantatlatertime,
because we observed gradual diminution of early apoptotic
cells and increment of the late apoptotic cells after 48h
(Figure 2(b)). These ﬁndings demonstrate that diosgenin
inducedtheapoptosisofHepG2cellsinbothdose-andtime-
dependent manners.
3.2. Eﬀect of Diosgenin on Activation of Caspases and Bcl-
2F a m i l y .Caspase activation is generally considered to be
a key hallmark of apoptosis. Mitochondria are involved in
a variety of key events leading to apoptosis, as releasing of
caspase activators, the production of reactive oxygen species
(ROS), and participation in regulation of both pro- and
anti-apoptotic bcl-2 family proteins [8]. In the next series
of experiment, we assessed the eﬀect of diosgenin on the
cascade of caspases that are crucial initiators and eﬀectors in4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: FACS analyses of Annexin V and PI staining. HepG2 cells was treated with diosgenin (0–40μM )f o r2 4h( a )a n d4 0μM for 0, 24,
48h (b). Lower right quadrant, early apoptosis cells, that is, Annexin V-FITC-positive/PI-negative cells; upper right quadrant, necrosis or
late-apoptotic cells, that is, Annexin V-FITC-positive/PI-positive cells.
various cell death pathways. As shown in Figure 3(a), dios-
genin treatment activated caspase-3, caspase-8 and caspase-9
(as shown by decreased procaspase-9 and -8 levels) followed
by subsequent PARP cleavage.
Bcl-2 family proteins are crucial for apoptosis commit-
ment, mainly via the control of the mitochondrial pathway
which is frequently triggered in response to chemother-
apeutic agents [25]. Elevated levels of Bcl-2 in tumor
cells may contribute to chemoresistance by stabilizing the
mitochondrial membrane against apoptotic insult. Bax and
Bak are the critical eﬀectors of apoptosis acting downstream
of the both the prosurvival and BH3-only members [26].
The BH3-only proteins (Bid, Bim, Puma, Noxa) are pro-
apoptotic and act as sensors of speciﬁc types of cellular stress
[27]. Thus, Bcl-2 family proteins may be good therapeutic
targets.
To investigate the cellular mechanism underlying
diosgenin-induced apoptosis in HepG2 cells, we analyzed
the expression of apoptosis-regulated genes; including
pro-survial Bcl-2, pore-forming Bax and pro-apoptotic Bid
proteins. As illustrated in Figure 3(b), the expression level
of Bcl-2 was gradually down-regulated as the diosgenin
concentration increased. In addition, diosgenin signiﬁcantly
induced the activation of Bax and Bid. Bid functions to
receive death signals in the cytosol from upstream events and
is cleaved to truncated Bid (tBid; 15). Upon translocation of
Bid to mitochondria, it induces the release of cytochrome
c. From subsequent experiments, we observed a higher
expression of cytochrome c. Cytochrome c release is not a
speciﬁc sign of apoptosis, which also occurs during necrotic
cell death [28]. However, our results also revealed the
increased levels of caspases and Bax and the decreased levelsEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Eﬀects of diosgenin on caspases (a), Bcl-2 family proteins, and cytochrome c (b). Cells were incubated without or with 20μM,
30μM, and 40μM of diosgenin for 24h. Total cell lysates were analyzed by immunoblotting with antibody against caspase-3 (pro and
cleavage), procaspase-8, procaspase-9, PARP, Bcl-2, Bax, Bid, and cytochrom c.
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Figure 4: Diosgenin generated ROS in HepG2 cells. (a) Diosgenin generated ROS in HepG2 cells. Cells were treated with diﬀerent
concentrations of diosgenin (20–40μM) plus 40μM of DCFH-DA for 24h, and ROS productions were determined by FACS analysis. (b)
For observation of intracellular ROS by ﬂuorescence microscope, cells were treated with diosgenin (20–40μM) and then incubated with
DCFH-DA.
of Bcl-2 and Bid. These results indicate that diosgenin leads
to a shift from antiapoptosis to proapoptosis by altering the
function of the proteins in the Bcl-2 family, which results in
the release of cytochrome c from mitochondria.
3.3.Diosgenin-InducedApoptosisbytheGenerationofReactive
Oxygen Species (ROS). As reactive oxygen species (ROS)
generation is an important role in apoptosis, we investigated
the ability of diosgenin to generate ROS. Cells were exposed
to diosgenin (0–40μM )f o r2 4 h ra n da n a l y z e df o rt h e
present of ROS by ﬂow cytometry The generation of ROS
by diosgenin was increased in dose-dependent manner
(Figure 4(a)). We also conﬁrmed intracellular ROS produc-
tion by ﬂuorescence microscope after staining with carboxy-
H2DCFDA, ROS were generated by treatment of diosgenin
(Figure 4(b)).Toexaminewhetherdiosgenin-generatedROS
induce apoptosis in HepG2 cells, we measured cell death
after treatment of diosgenin only or with NAC. NAC is6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Diosgenin-generated ROS induced apoptosis in HepG2 cells. (a) The cells were pretreated with/without NAC (10mM) at least
2hr before the treatment of 40μM diosgenin. After 24h, quantitative assessment of the percentage of cell viability was determined by MTT
assay. ∗∗P<0.01 compared to control, ##P<0.01 compared to diosgenin 40μM-treated group. (b) Also cells were pretreated with/without
NAC (10mM) at least 2h before the treatment of diosgenin. ROS production was conﬁrmed by ﬂuorescence microscope.
a potent antioxidant that can inhibit oxidative stress by
directly scavenging ROS and replenishing GSH [29]. If
ROS production mediates diosgenin-induced cell death,
we expect that NAC should have the ability to inhibit
diosgenin-induced cell death. As shown in Figure 5(a),
diosgenin (40μM) increased cell death, whereas removing
diosgenin-generated ROS by NAC led to decreasing cell
death. Also, the decrement of intracellular ROS by treating
NAC was observed after DCFH-DA staining (Figure 5(b)).
These results indicate that diosgenin induced cell death of
HepG2 cells by the generation of ROS.
3.4. Diosgenin-Activated MAPKs and ASK1. Intracellular
MAPKs are the major oxidative stress-sensitive signal trans-
duction pathways [16]. The major enzymes belonging
to MAPKs are the extracellular signal regulating kinase
1/2(ERK1/2 or p44/42 MAPK), c-Jun N-terminal kinase
(JNK), and p38 MAPK. JNK and p38 are stress-activated
MAP kinases that are preferentially activated by cytotoxic
stress,suchasX-ray/UVirradiation,heat/osmoticshock,and
oxidative/nitrosative stress [19, 30]. To identify the signaling
pathways involved in diosgenin-induced cell death, HepG2
cells were treated with 40μM diosgenin, and activation of
MAPKs was determined by Western blotting. As illustrated
in Figure 6(a),p38 MAPKandJNK activationinHepG2cells
was induced by diosgenin.
Next, we measured the phosphorylation levels of ASK1
for determining ASK1 activation. Our results showed that
ASK1 phosphorylation was increased at 60min, and sus-
tained to 240min by diosgenin (Figure 6(b)). ASK1 is an
upstream kinase of JNK and p38 MAPK [31]. JNK and p38
MAPK are activated through ASK1 in response to various
extracelluar stimuli [21, 32]. The binding of ASK1 to TNF
receptor-associated factor or death domain-associated pro-
tein stimulates ASK1 function, whereas the ASK1 inhibitory
proteins such as thioredoxin downregulate proapoptotic
activity of ASK1 [33, 34]. Recent studies have suggested that
R O S - m e d i a t e dA S K 1a c t i v a t i o ni si n v o l v e di nav a r i e t yo f
disorders, such as inﬂammation [13, 14], neurodegeneration
[15,16],andcardiachypertrophyandremodeling[18,19].It
hasalreadybeenreportedthatEGCGandberberineexecuted
apoptoticcelldeathviaanASK1andJNK/p38cascade,which
is induced by NAC-sensitive intracellular oxidation or ROS
[35–37]. In this study, diosgenin activated JNK, p38 MAPK
a n dA S K 1a sw e l la sR O Sg e n e r a t i o n .T h e r e f o r e ,f u r t h e r
studiesonthemechanismsofregulationofASK1activityand
the development of ASK1-targeting drugs may contribute to
the treatment of various diseases caused by oxidative stress.
4. Conclusion
In conclusion, the present data showed that diosgenin
induced apoptosis in HepG2 cells through Bcl-2 pro-
tein family- (Bcl-2, Bax, and Bid)-mediated mitochondria/
caspase-3-dependent pathway. Also, diosgenin strongly gen-
erated ROS and this oxidative stress might induce apoptosis
through activation of ASK1, which are critical upstream
signals for JNK/p38 MAPK activation in HepG2 cancer cells.Evidence-Based Complementary and Alternative Medicine 7
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Figure 6: Eﬀects of diosgenin on MAPK (a) and ASK1 (b).
Cells were treated with varying concentrations of diosgenin (20–
40μM) for 24h. Total cell lysates were analyzed by immunoblotting
with antibody against phospho-p38, p38, phospho-JNK, JNK,
phosphoASK1, and ASK1.
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